Medical Dialogues
  • Dermatology
Sign in Signup
This site is intended for healthcare professionals only
Sign in Signup
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
Sign InRegister
Medical Dialogues
Sign inRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
  • Case of the Day
  • Editorial
  • Home
  • Pediatrics and Neonatology
  • Pediatrics and Neonatology News
  • Phenobarbital and...

Phenobarbital and Levetiracetam frontline drugs to control neonatal seizures, finds study

MD Editorial TeamBy MD Editorial TeamPublished On 2021-12-15T09:00:18+05:30  |  Updated On 2021-12-15T09:00:31+05:30
Phenobarbital and Levetiracetam frontline drugs to control neonatal seizures, finds study

In a new study conducted by Zhen-E Xu and team, it was found that Phenobarbital is recommended as the first-line treatment for newborn seizures. Furthermore, levetiracetam appears to be an effective second-line therapy for newborn seizures once first-line medicines fail. The findings of this study were published in the Journal Pediatrics & Neonatology.Anti-epileptic medications have...

In a new study conducted by Zhen-E Xu and team, it was found that Phenobarbital is recommended as the first-line treatment for newborn seizures. Furthermore, levetiracetam appears to be an effective second-line therapy for newborn seizures once first-line medicines fail.

The findings of this study were published in the Journal Pediatrics & Neonatology.

Anti-epileptic medications have varying effects on newborn seizures, and novel treatments have become widely utilized in recent years. Meanwhile, there are still considerable disparities in the management of newborn seizures, whether in terms of medication choice or length of treatment. And, as therapy choices have expanded, the optimal choice of second-line treatment has not been advised.

The databases MEDLINE, the Cochrane Library, Web of Science, Embase, and clinicaltrials.gov were searched for this study (January 1, 1960 to October 20, 2020). We chose randomized controlled trials (RCTs) or observational studies on anti-epileptic medications for newborn seizures. The researchers then performed a network meta-analysis to compare the effectiveness of first-line and second-line anti-epileptic medications for newborn seizures.

The results were stated as follow:

1. The databases MEDLINE, the Cochrane Library, Web of Science, Embase, and clinicaltrials.gov were searched for this study (January 1, 1960 to October 20, 2020).

2. Researchers chose randomized controlled trials (RCTs) or observational studies on anti-epileptic medications for newborn seizures.

3. The team then performed a network meta-analysis to compare the effectiveness of first-line and second-line anti-epileptic medications for newborn seizures.

4. According to the statistics, phenobarbital was more successful as a first-line therapy than levetiracetam and phenytoin.

5. When administered as a second-line treatment, phenobarbital was more effective than any other medicine.

6. At the same time, midazolam was shown to be more effective than lidocaine in suppressing seizures.

7. In terms of secondary results, levetiracetam is less likely than phenobarbital to have long-term deleterious consequences in newborns.

Because more credible data are lacking, phenobarbital is advised as the first-line therapy for newborn seizures, taking into account available factors such as effectiveness, toxicity, and adverse effects. Furthermore, independent of effectiveness or mortality rate, phenytoin performed better as a first-line treatment than all other medicines except phenobarbital. Furthermore, levetiracetam appears to be an effective second-line therapy for newborn seizures once first-line medicines fail. In conclusion, the quality of our study is inadequate due to a lack of appropriate RCTs and other factors. As a result, larger, more standardized, and long-term investigations are necessary.

Reference:

Xu, Z.-E., Li, W.-B., Qiao, M.-Y., Cui, H.-T., Zhao, L.-Z., Chen, Q.-X., & Miao, J.-K. (2021). Comparative efficacy of anti-epileptic drugs for neonatal seizures: A network meta-analysis. In Pediatrics & Neonatology (Vol. 62, Issue 6, pp. 598–605). Elsevier BV. https://doi.org/10.1016/j.pedneo.2021.06.005

Journal of Pediatrics and Neonatology seizures Antiepileptic drugs levetiracetam 
Source : Journal Pediatrics & Neonatology
MD Editorial Team
MD Editorial Team

    Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable  connection

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Review: Efficacy of Antiviral Agents Against  Omicron Subvariant BA.2

    Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    View All

    Journal Club Today

    Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning

    Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning

    View All

    Health News Today

    Health Bulletin 20/May/2022

    Health Bulletin 20/May/2022

    View All
    © 2019 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X